1 minute read
MEDICAL ONCOLOGY
OPEN TO RECRUITMENT — AUSTRALIA & NEW ZEALAND
Abbrev. Title
MS100070_0119 JAVELIN Bladder Medley
Protocol Title
A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress with First Line Platinum-Containing Chemotherapy
OP-1250-001
A Phase 1/2 Open-label, First-in-Human, Multicenter, Dose Escalation and Dose Expansion Study of OP-1250 Monotherapy in Adult Subjects with Advanced and/or Metastatic Hormone Receptor (HR)-Positive, HER2-negative Breast Cancer
OP-1250-002
A Phase 1/2 Open-label, First-in-Human, Multicenter, Dose Escalation and Dose Expansion Study of OP-1250 Monotherapy in Adult Subjects with Advanced and/or Metastatic Hormone Receptor (HR)-Positive, HER2-negative Breast Cancer
OP-1250-002
A Phase 1/2 Open-label, First-in-Human, Multicenter, Dose Escalation and Dose Expansion Study of OP-1250 Monotherapy in Adult Subjects with Advanced and/or Metastatic Hormone Receptor (HR)-Positive, HER2-negative Breast Cancer
R2810-ONC-1788 C-POST A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab versus Placebo After Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma
R2810-ONC-1788 C-POST A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab versus Placebo After Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma
R3767-ONC-2011 HARMONY
A Phase 3 Trial of Fianlimab (REGN3767, Anti-LAG-3) + Cemiplimab Versus Pembrolizumab in Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
Real-PRO
Registry-Based Study of Enzalutamide Vs Abiraterone assessing Cognitive Function in Elderly Metastatic Castration-Resistant Prostate Cancer
RLY-4008-101 REFOCUS A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumours
SHR2002-102
A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SHR-2002 Injection in Combination with SHR-1316 in Patients with Advanced Malignant Tumours
